Respiratory Syncytial Virus (RSV) News and Research

Latest Respiratory Syncytial Virus (RSV) News and Research

Zoonotic origins of seasonal human coronaviruses

In a recent study posted to the bioRxiv* preprint server, investigators analyzed the evolution and origin of seasonal human coronaviruses (sHCoVs).

8 Jun 2022

Broad-spectrum polymeric antivirals against SARS-CoV-2

In a recent study published in the journal Advanced Science, researchers evaluated the potential and applicability of macromolecular viral inhibitors against respiratory viral pathogens.

17 May 2022

Study explores macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with anti-SARS-CoV-2 activities

Researchers created polystyrene sulfonate with significantly different molar masses, constructed these polymers as an exterior around spherical gold nanoparticles of various sizes to improve multivalency effects, measured antiviral effects of the antivirals on numerous viruses in vitro, and investigated the method of interaction of the leads with SARS-CoV-2 and lentiviral particles.

13 May 2022

Study shows reduced respiratory syncytial virus antibody levels in women of childbearing age and infants during the COVID-19 pandemic

A study demonstrated that the humoral immunity against the respiratory syncytial virus (RSV) has significantly reduced.

12 May 2022

Evidence of croup associated with SARS-CoV-2

A new study published in the Journal of Pediatric Infectious Diseases Society aimed to characterize the clinical features of SARS-CoV-2-associated croup among children presenting to the ED during the phase when Omicron variant transmission was high.

9 May 2022

Exploring changes in non-COVID-19 hospitalization rates before and during COVID-19

Researchers assessed the trends in non-COVID-19 hospitalizations before and during the COVID-19 pandemic in the United States between 2017 and 2021.

2 May 2022

Probenecid shows activity against respiratory syncytial virus

A new study describes the antiviral activity of the approved drug probenecid against respiratory syncytial virus.

29 Apr 2022

Children treated with antibiotics have abundant fungal microbiota in the gut, study reveals

A study recently completed at the University of Helsinki revealed that the fungal microbiota in the gut is more abundant and diverse in children treated with antibiotics compared with the control group even six weeks following the start of the antibiotic course.

29 Apr 2022

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

Researchers investigate the rates at which different pathogens appear in children, both independently and alongside SARS-CoV-2.

21 Apr 2022

Study reveals natural infection of pangolins with human RSV

A new study aimed to determine whether humans were able to transmit RSV to Malayan pangolins.

13 Apr 2022

Patient outcomes after influenza, RSV, or SARS-CoV-2 hospitalization

A recent study posted to the medRxiv* preprint server investigated the elements that predicted all-cause mortality among individuals hospitalized due to influenza, respiratory syncytial virus (RSV), or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

7 Apr 2022

Direction and magnitude of predictors of all-cause mortality following hospitalization with influenza, RSV, or SARS-CoV-2

Researchers performed a retrospective cohort study to identify predictors of mortality following hospitalization with influenza, respiratory syncytial virus, or SARS-CoV-2.

5 Apr 2022

Study investigates whether coinfection with multiple SARS-CoV-2 variants exists in COVID-19 patients

A new study shows that multiple variants of this virus may coinfect the same patient, using both genomic sequencing data and computational models.

30 Mar 2022

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

A recent paper examines the occurrence of other respiratory viral infections during this period in patients already infected with SARS-CoV-2.

29 Mar 2022

COVID-19-related hospitalization among infants and young children in the US

Researchers investigated COVID-19-associated hospitalization among children and infants aged zero to four years in the United States during March 2020 and February 2022.

18 Mar 2022

Impact of COVID-19 measures on the future transmission of respiratory syncytial virus

A new study discussed the impact of COVID-19 measures on the future transmission of the respiratory syncytial virus in South Africa.

17 Mar 2022

Single dose of new drug nirsevimab provides safe protection against RSV in healthy infants

The new drug nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled phase 3 clinical trial published in the New England Journal of Medicine.

9 Mar 2022

Virginia Tech-led researchers to investigate the transmission of flu in child care settings

In January, the Centers for Disease Control and Prevention (CDC) updated its guidance for reducing SARS-CoV-2 (COVID-19) transmission in schools and day care settings.

6 Mar 2022

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled Phase 3 clinical trial.

3 Mar 2022

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Antibiotics provide no benefit in preventing future recurrent wheezing in babies hospitalized with respiratory syncytial virus (RSV), according to a new study led by Washington University School of Medicine in St. Louis. And there is some evidence that antibiotics may make wheezing worse.

27 Feb 2022

Respiratory Syncytial Virus (RSV) News and Research

Latest Respiratory Syncytial Virus (RSV) News and Research

Zoonotic origins of seasonal human coronaviruses

Broad-spectrum polymeric antivirals against SARS-CoV-2

Study explores macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with anti-SARS-CoV-2 activities

Study shows reduced respiratory syncytial virus antibody levels in women of childbearing age and infants during the COVID-19 pandemic

Evidence of croup associated with SARS-CoV-2

Exploring changes in non-COVID-19 hospitalization rates before and during COVID-19

Probenecid shows activity against respiratory syncytial virus

Children treated with antibiotics have abundant fungal microbiota in the gut, study reveals

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

Study reveals natural infection of pangolins with human RSV

Patient outcomes after influenza, RSV, or SARS-CoV-2 hospitalization

Direction and magnitude of predictors of all-cause mortality following hospitalization with influenza, RSV, or SARS-CoV-2

Study investigates whether coinfection with multiple SARS-CoV-2 variants exists in COVID-19 patients

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

COVID-19-related hospitalization among infants and young children in the US

Impact of COVID-19 measures on the future transmission of respiratory syncytial virus

Single dose of new drug nirsevimab provides safe protection against RSV in healthy infants

Virginia Tech-led researchers to investigate the transmission of flu in child care settings

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Respiratory Syncytial Virus (RSV) News and Research

Latest Respiratory Syncytial Virus (RSV) News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in